XML 38 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation (Tables)
3 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Adoption of New Revenue Recognition Standard Revenue Impacted Previously Reported

Adoption of new revenue recognition standard impacted the Company’s previously reported results as follows:

 

 

Three months ended

 

 

September 30, 2017

 

 

As Previously Reported

 

ASC606 Adjustments

 

As Restated

 

Consolidated Statements of Operations:

 

 

 

 

 

 

 

 

 

Total Revenue

$

187.9

 

$

(9.1

)

$

178.8

 

Selling, general and administrative expense

 

115.2

 

 

(8.0

)

 

107.2

 

Income tax provision

 

4.8

 

 

(0.3

)

 

4.5

 

Net Income attributable to Myriad Genetics, Inc. stockholders

 

79.6

 

 

(0.8

)

 

78.8

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

$

1.16

 

$

(0.01

)

$

1.15

 

Diluted

$

1.13

 

$

(0.01

)

$

1.12

 

Consolidated Statements of Cash Flows:

 

 

 

 

 

 

 

 

 

Net Income attributable to Myriad Genetics, Inc. stockholders

 

79.6

 

 

(0.8

)

$

78.8

 

Trade Accounts Receivable

 

(16.5

)

 

10.3

 

 

(6.2

)

 

 

June 30, 2018

 

 

As Previously Reported

 

ASC606 Adjustments

 

As Restated

 

Consolidated Balance Sheet:

 

 

 

 

 

 

 

 

 

Trade accounts receivable

$

98.3

 

$

1.2

 

$

99.5

 

Retained Earnings

 

52.9

 

 

1.2

 

 

54.1